We Can REDUCE-IT!
- Cardio
- 17/04/2019
Findings from the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) show that icosapent ethyl, a purified ethyl ester of eicosapentaenoic acid (EPA) reduces...
READ MOREFindings from the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) show that icosapent ethyl, a purified ethyl ester of eicosapentaenoic acid (EPA) reduces...
READ MOREMost people these days face some form of stress. It might be due to work pressure, loss of a loved one, a life-threatening illness, violence, a natural disaster, etc. More and more evidence now...
READ MOREIn a major medical breakthrough, Tel Aviv University researchers have "printed" the world's first 3D vascularised engineered heart using a patient's own cells and biological materials. Their...
READ MOREA new study shows that incorporating modern deep machine learning networks into prognostic models is feasible in congenital heart disease. The researchers used data from over 10 000 patients...
READ MOREA new analysis suggests that women are under-represented in landmark heart failure clinical trials. In the PARADIGM-HF trial, the use of sacubitril-valsartan reduced heart failure hospi
READ MOREHeart failure patients who could possibly benefit from a newer class of drug to lower their heart rate were more likely to take the medication if it was prescribed before hospital discharge rathe
READ MOREIn a recent study study, surveillance data from 4 US communities was used to associate monthly influenza-like illness (ILI) activity as reported by the CDC with MI and HF hospitalisations. I
READ MOREThe 2019 American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines on Primary Prevention of Cardiovascular Disease were released at the recent ACC annual scientific meeting
READ MOREAccording to new research published in the Journal of the American Heart Association, many patients who could benefit from statins do not take them. Statins lower the amount of LDL and
READ MOREA South Korean study of more than 196,000 patients with atrial fibrillation (AF) showed that blood pressure control in mid-life could reduce the risk of AF-associated dementia. The findings were...
READ MORE